Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
American Regent, Inc.
The primary objective of this study is to evaluate the long term safety and tolerability of an iron maintenance dosing strategy utilizing VIT45 in the treatment of anemia of non-dialysis dependent chronic kidney disease (NDD-CKD). This study is a long term extension to protocol 1VIT04004.
In this study patients that complete protocol 1VIT 04004 or are discontinued will be offered to participate in this extension study.
Age
12–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects who completed or discontinued Protocol 1VIT04004
You may not be if
Known hypersensitivity reaction to VIT-45
Anemia not related to CKD
Chronic, serious infection
Recent IV iron other than study drug in past 12 weeks
